Global Clinical Experience CRF Health has extensive experience supporting over 800 clinical trials across 74 countries and in more than 100 languages, demonstrating a proven track record in delivering patient-centric eSource solutions worldwide. This broad global presence presents opportunities for international expansion and tailored solutions for multinational pharmaceutical clients.

Innovative Product Portfolio The company offers industry-leading solutions such as TrialMax® and TrialConsent® with a focus on eCOA and electronic informed consent, emphasizing high data accuracy and patient engagement. These innovative, fully integrated platforms open doors to upsell advanced modules and expand into integrated digital trial ecosystems.

Strong Industry Recognition Winning awards and launching multiple version upgrades of TrialConsent showcases CRF Health's commitment to innovation and client satisfaction. This positions the company favorably when approaching prospects looking for reliable, award-winning technology solutions in the life sciences sector.

Acquisition and Growth Momentum Following Genstar Capital’s acquisition in 2018 and the company’s subsequent growth initiatives, including self-service models and customer enablement programs, there is a clear momentum for scaling. These developments suggest opportunities to offer complementary solutions or integration services to support their expansion efforts.

Targeted Client Base CRF Health primarily serves CROs and pharmaceutical sponsors seeking patient-centered eSource tools for clinical trials. Business development efforts can focus on expanding into new therapeutic areas or offering complementary services such as data analytics, training, or implementation support to deepen existing client relationships.